Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

Autor: Aarnoutse, RE, Kibiki, GS, Reither, K, Semvua, HH, Haraka, F, Mtabho, CM, Mpagama, SG, van den Boogaard, J, Sumari-de Boer, IM, Magis-Escurra, C, Wattenberg, M, Logger, JGM, Te Brake, LHM, Hoelscher, M, Gillespie, SH, Colbers, A, Phillips, PPJ, Plemper van Balen, G, Boeree, MJ, PanACEA Consortium

Publikováno v: Antimicrobial agents and chemotherapy, vol 61, iss 11

In a multiple-dose-ranging trial, we previously evaluated higher doses of rifampin in patients for 2 weeks. The objectives of the current study were to administer higher doses of rifampin for a longer period to compare the pharmacokinetics, safety/to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::043f76518f850ff5ff1b1fe1ccf9a781
https://escholarship.org/uc/item/08z4903k

Concentrations of respirable crystalline silica and radon among tanzanite mining communities in Mererani, Tanzania.

Autor: Mbuya AW; Department of Community Health, Institute of Public Health, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania.; Department of Community Health, Kibong'oto Infectious Diseases Hospital, Mae Street, P. O. Box 12, Sanya Juu, Kilimanjaro, Tanzania., Mboya IB; Department of Community Health, Institute of Public Health, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania.; Department of Epidemiology and Biostatistics, Institute of Public Health, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania., Semvua HH; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Center, P. O. Box 3010, Moshi, Tanzania., Msuya SE; Department of Community Health, Institute of Public Health, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania.; Department of Epidemiology and Biostatistics, Institute of Public Health, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania.; Department of Community Health, Kilimanjaro Christian Medical Center, P. O. Box 3010, Moshi, Tanzania., Howlett PJ; National Heart & Lung Institute, Imperial College London, Emmanuel Kaye, Royal Brompton Campus, 1B Manresa Road, London, SW3 6LR, United Kingdom., Mamuya SH; Department of Environmental and Occupational Health, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Upanga West, Ilala, P. O. Box 65001, Dar es Salaam, Tanzania.

Publikováno v: Annals of work exposures and health [Ann Work Expo Health] 2024 Jan 08; Vol. 68 (1), pp. 48-57.

Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania.

Autor: Mbuya AW; Department of Community Health, Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.; Department of Community Health, Kibong'oto Infectious Diseases Hospital, Sanya Juu, Kilimanjaro, Tanzania., Mboya IB; Department of Community Health, Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.; Department of Epidemiology and Biostatistics, Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania., Semvua HH; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Center, Moshi, Tanzania., Mamuya SH; Department of Environmental and Occupational Health, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Msuya SE; Department of Community Health, Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.; Department of Epidemiology and Biostatistics, Institute of Public Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.; Department of Community Health, Kilimanjaro Christian Medical Center (KCMC), Moshi, Tanzania.

Publikováno v: PloS one [PLoS One] 2023 Mar 15; Vol. 18 (3), pp. e0280396. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).

Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.

Autor: Sumari-de Boer M; Kilimanjaro Clinical Research Institute (KCRI), PO Box 2236, Moshi, Tanzania. m.sumari@kcri.ac.tz.; Department of International Health, RadboudUMC, Nijmegen, the Netherlands. m.sumari@kcri.ac.tz., Pima FM; Kilimanjaro Clinical Research Institute (KCRI), PO Box 2236, Moshi, Tanzania., Ngowi KM; Kilimanjaro Clinical Research Institute (KCRI), PO Box 2236, Moshi, Tanzania.; Department of Medical Psychology, Amsterdam UMC, Amsterdam, the Netherlands.; Medical psychologypsychology, AMC, AZ, 9 1105, Meibergdreef, Amsterdam, Netherlands., Chelangwa GM; National Tuberculosis and Leprosy Programme, Dar es Salaam, Tanzania., Mtesha BA; Kilimanjaro Clinical Research Institute (KCRI), PO Box 2236, Moshi, Tanzania., Minja LM; Kilimanjaro Clinical Research Institute (KCRI), PO Box 2236, Moshi, Tanzania., Semvua HH; Kilimanjaro Clinical Research Institute (KCRI), PO Box 2236, Moshi, Tanzania., Mpagama S; Kibong'oto Infectious Diseases Hospital, Sanya Juu, Tanzania., Mmbaga BT; Kilimanjaro Clinical Research Institute (KCRI), PO Box 2236, Moshi, Tanzania., Nieuwkerk PT; Department of Medical Psychology, Amsterdam UMC, Amsterdam, the Netherlands., Aarnoutse RE; Department of Clinical Pharmacology, RadboudUMC, Nijmegen, the Netherlands.

Publikováno v: Trials [Trials] 2019 Jul 12; Vol. 20 (1), pp. 426. Date of Electronic Publication: 2019 Jul 12.

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.

Autor: Aarnoutse RE; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Kibiki GS; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania., Reither K; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Semvua HH; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania., Haraka F; Ifakara Health Institute, Bagamoyo, Tanzania., Mtabho CM; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania., Mpagama SG; Kibong'oto National Tuberculosis Hospital, Sanya Juu, Tanzania., van den Boogaard J; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Sumari-de Boer IM; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.; Radboud University Medical Center, Department of Internal Medicine, Nijmegen, the Netherlands., Magis-Escurra C; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Wattenberg M; Radboud University Medical Center, Department of Medical Microbiology, Nijmegen, the Netherlands., Logger JGM; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands., Te Brake LHM; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands Lindsey.teBrake@radboudumc.nl.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Hoelscher M; Medical Centre of the University of Munich (LMU), Division of Infectious Diseases and Tropical Medicine, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Gillespie SH; School of Medicine, University of St. Andrews, North Haugh, St. Andrews, United Kingdom., Colbers A; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Phillips PPJ; MRC Clinical Trials Unit at UCL, London, United Kingdom., Plemper van Balen G; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Boeree MJ; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Oct 24; Vol. 61 (11). Date of Electronic Publication: 2017 Oct 24 (Print Publication: 2017).